Cite
The Role of Bromodomain Testis-Specific Factor, BRDT, in Cancer: A Biomarker and A Possible Therapeutic Target.
MLA
Bourova-Flin, Ekaterina, et al. “The Role of Bromodomain Testis-Specific Factor, BRDT, in Cancer: A Biomarker and A Possible Therapeutic Target.” Cell Journal (Yakhteh), vol. 19, Apr. 2017, pp. 1–8. EBSCOhost, https://doi.org/10.22074/cellj.2017.5060.
APA
Bourova-Flin, E., Chuffart, F., Rousseaux, S., & Khochbin, S. (2017). The Role of Bromodomain Testis-Specific Factor, BRDT, in Cancer: A Biomarker and A Possible Therapeutic Target. Cell Journal (Yakhteh), 19, 1–8. https://doi.org/10.22074/cellj.2017.5060
Chicago
Bourova-Flin, Ekaterina, Florent Chuffart, Sophie Rousseaux, and Saadi Khochbin. 2017. “The Role of Bromodomain Testis-Specific Factor, BRDT, in Cancer: A Biomarker and A Possible Therapeutic Target.” Cell Journal (Yakhteh) 19 (April): 1–8. doi:10.22074/cellj.2017.5060.